Truncating Lactoferrampin Peptide: Which Parts Are Essential for Antimicrobial Activity?
Systematic C- and N-terminal truncation of lactoferrampin (LFampin 265-284) revealed the minimal active sequence needed for antimicrobial activity versus biophysical membrane interaction — not all structure-activity matches.
Quick Facts
What This Study Found
Systematic C- and N-terminal truncation of lactoferrampin (LFampin 265-284) revealed the minimal active sequence needed for antimicrobial activity versus biophysical membrane interaction — not all structure-activity matches.
Key Numbers
How They Did This
research study.
Why This Research Matters
Relevant for peptide research.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
Trust & Context
- Key Stat:
- Key finding Systematic C- and N-terminal truncation of lactoferrampin (LFampin 265-284) revealed the minimal active sequence needed for antimicrobial activity ver
- Evidence Grade:
- emerging evidence.
- Study Age:
- Published in 2011.
- Original Title:
- C- and N-truncated antimicrobial peptides from LFampin 265 - 284: Biophysical versus microbiology results.
- Published In:
- Journal of pharmacy & bioallied sciences, 3(1), 60-9 (2011)
- Authors:
- Adão, Regina(2), Nazmi, Kamran(10), Bolscher, Jan G M(9), Bastos, Margarida
- Database ID:
- RPEP-01728
Evidence Hierarchy
Frequently Asked Questions
What was studied?
Truncating Lactoferrampin Peptide: Which Parts Are Essential for Antimicrobial Activity?
What was found?
Systematic C- and N-terminal truncation of lactoferrampin (LFampin 265-284) revealed the minimal active sequence needed for antimicrobial activity versus biophysical membrane interaction — not all structure-activity matches.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01728APA
Adão, Regina; Nazmi, Kamran; Bolscher, Jan G M; Bastos, Margarida. (2011). C- and N-truncated antimicrobial peptides from LFampin 265 - 284: Biophysical versus microbiology results.. Journal of pharmacy & bioallied sciences, 3(1), 60-9. https://doi.org/10.4103/0975-7406.76467
MLA
Adão, Regina, et al. "C- and N-truncated antimicrobial peptides from LFampin 265 - 284: Biophysical versus microbiology results.." Journal of pharmacy & bioallied sciences, 2011. https://doi.org/10.4103/0975-7406.76467
RethinkPeptides
RethinkPeptides Research Database. "C- and N-truncated antimicrobial peptides from LFampin 265 -..." RPEP-01728. Retrieved from https://rethinkpeptides.com/research/adao-2011-c-and-ntruncated-antimicrobial
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.